Literature DB >> 6181165

Clonally restricted natural killer-like cytotoxicity displayed by cloned human T cell lines.

G P Pawelec, M R Hadam, E M Schneider, P Wernet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6181165

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  9 in total

1.  Cellular immunological defects of chronic myelogenous leukaemics: partial dependence on busulphan therapy.

Authors:  G Pawelec; H Schmidt; E Schneider; H J Bühring; G Ehninger
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 2.  Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity?

Authors:  B M Vose
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  NK cells can recognize asialylated autologous lymphocytes and ABO-mismatched lymphocytes.

Authors:  C M Rooney; A J Munro
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

4.  CD4+ CD45R- suppressor-inducer T-cell clones: requirements for cellular interaction, proliferation and lymphokines for the induction of suppression in peripheral blood mononuclear cells.

Authors:  G Pawelec
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

5.  Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patients.

Authors:  G Pawelec; G Ehninger; H Schmidt; C Müller; H J Bühring; M Reutter; F W Busch
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  Functionally distinct human T-lymphocyte clones sharing potent suppressive activity on immunoglobulin secretion.

Authors:  F Falcioni; G Pawelec; N Brattig; E M Schneider; P Berg; P Wernet
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

7.  Production of multiple cytokines by clones of human large granular lymphocytes.

Authors:  P Allavena; G Scala; J Y Djeu; A D Procopio; J J Oppenheim; R B Herberman; J R Ortaldo
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  Modulation of in vitro myelopoiesis by alloreactive T cell clones.

Authors:  F W Busch; P Wernet; P Meyer; E M Schneider; G Pawelec
Journal:  Blut       Date:  1986-05

9.  Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinoside.

Authors:  G Pawelec; H Schmidt; A Rehbein; F Busch
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.